Radiolabeling Strategies for Radionuclide Imaging of Stem Cells

被引:0
作者
Esther Wolfs
Catherine M. Verfaillie
Koen Van Laere
Christophe M. Deroose
机构
[1] Department of imaging and pathology,Division of nuclear medicine and molecular imaging/ Molecular small animal imaging centre (MoSAIC)
[2] KU Leuven,Department of development and regeneration
[3] Stem Cell Institute,Division of Nuclear Medicine Campus Gasthuisberg
[4] KU Leuven,undefined
[5] UZ Leuven,undefined
来源
Stem Cell Reviews and Reports | 2015年 / 11卷
关键词
Stem cells; Radiolabeling; Molecular imaging; PET; SPECT;
D O I
暂无
中图分类号
学科分类号
摘要
The interest in the use of stem cells as a source for therapy has increased dramatically over the last decades. Different stem cell types have been tested in both in vitro and in vivo models, because of their properties such as differentiation potential, trophic effects and immune modulatory properties. To further optimize the use of different stem cell types for the treatment of disease in a clinical setting, it is necessary to know more about the in vivo behavior of these cells following engraftment. Until now, the golden standard to preclinically evaluate cell therapy was histology, which is an invasive method as the animals need to be sacrificed. This hampers the generation of dynamic information and results in only one single point in time available for analysis per animal. For more information regarding cell migration, in situ persistence, viability, proliferation and differentiation, molecular imaging can be used for imaging cells after transplantation dynamically and longitudinally, in a noninvasive way. With this technology, it becomes possible to track cells within the same subjects over a long period of time.
引用
收藏
页码:254 / 274
页数:20
相关论文
共 615 条
  • [21] Jacobs RE(2003)111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction Nuclear Medicine Communications 24 1149-54
  • [22] Cherry SR(2004)111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model Journal of Nuclear Medicine 45 512-8
  • [23] Phelps ME(2007)Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells European Journal of Nuclear Medicine and Molecular Imaging 34 715-21
  • [24] Hoffman EJ(2013)Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats Experimental Neurology 239 158-62
  • [25] Mullani NA(2005)Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction Circulation 112 1451-61
  • [26] Ter-Pogossian MM(2011)In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis Nuclear Medicine and Biology 38 961-7
  • [27] Vastenhouw B(2007)Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure Experimental Hematology 35 1884-90
  • [28] Beekman F(2007)In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease The Quarterly Journal of Nuclear Medicine and Molecular Imaging 51 61-6
  • [29] Jones T(1995)Radiolabelled lymphocyte migration in rheumatoid synovitis Annals of the Rheumatic Diseases 54 39-44
  • [30] Rabiner EA(2009)Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution Cell Transplantation 18 1369-79